Live Oak Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Sell
13,637
-12,795
-48% -$1.48M 0.97% 25
2025
Q4
$2.78M Buy
26,432
+1,465
+6% +$138K 1.71% 19
2025
Q3
$2.1M Buy
24,967
+1,018
+4% +$83.8K 1.39% 22
2025
Q2
$1.9M Buy
23,949
+16,202
+209% +$1.29M 1.46% 21
2025
Q1
$695K Buy
+7,747
New +$723K 0.55% 51
2024
Q4
Hold
0
49
2024
Q3
Hold
0
15
2024
Q2
Hold
0
13
2023
Q4
Hold
0
11
2023
Q3
Hold
0
14
2023
Q2
Hold
0
15
2023
Q1
Hold
0
15
2022
Q4
Hold
0
14

Other funds holding MRK

Live Oak Investment Partners's MRK Position: Q1 2026 in Review

Live Oak Investment Partners reduced its Merck (MRK) stake by 48% in Q1 2026, selling an estimated $1.48M and leaving 13,637 shares worth $1.64M. The position accounts for 0.97% of the portfolio, ranked #25.

Live Oak Investment Partners first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.78M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Live Oak Investment Partners held 13,637 shares of Merck worth $1.64M as of Q1 2026.
  • Live Oak Investment Partners sold 12,795 Merck shares in Q1 2026, an estimated $1.48M.
  • Merck made up 0.97% of Live Oak Investment Partners's portfolio in Q1 2026, its #25 holding.
  • Live Oak Investment Partners first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • Live Oak Investment Partners's Merck position peaked at $2.78M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Live Oak Investment Partners's 13F filing for Q1 2026, filed 29 Apr 2026.